Influence of host genetic variation on rubella-specific T cell cytokine responses following rubella vaccination

Vaccine

Volumn 27, Issue 25-26, 2009, Pages 3359-3366

  Ovsyannikova, Inna G ^a   Ryan, Jenna E ^a   Vierkant, Robert A ^a   O'Byrne, Megan M ^a   Pankratz, V Shane ^a   Jacobson, Robert M ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cellular responses; Cytokines; ELISA; ELISPOT; HLA alleles; Rubella vaccine

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MEASLES MUMPS RUBELLA VACCINE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CELL CULTURE; CELLULAR IMMUNITY; CHILD; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GROUPS BY AGE; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INNATE IMMUNITY; MALE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RUBELLA; RUBELLA VIRUS; SCHOOL CHILD; STIMULATION; SUPERNATANT; TH1 CELL; TH2 CELL; VACCINATION;

ADOLESCENT; ADULT; ALLELES; CHILD; CYTOKINES; FEMALE; GENETIC VARIATION; HLA ANTIGENS; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-10; MALE; POLYMORPHISM, GENETIC; RUBELLA VACCINE; T-LYMPHOCYTES; VACCINATION;

EID: 67349268939     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.079     Document Type: Article

References (30)

1. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., and Poland G.A. The contribution of HLA class I antigens in immune status following two doses of rubella vaccination. Hum Immunol 65 (2004) 1506-1515
2. Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Jacobsen S.J., Pankratz V.S., and Poland G.A. Human leukocyte antigen class II alleles and rubella-specific humoral and cell-mediated immunity following measles-mumps-rubella-II vaccination. J Infect Dis 191 4 (2005) 515-519
3. Marsh S.G., Albert E.D., Bodmer W.F., Bontrop R.E., Dupont B., Erlich H.A., et al. Nomenclature for factors of the HLA system. Hum Immunol 63 12 (2002) 1213-1268
4. Tan P.-L., Jacobson R.M., Poland G.A., Jacobsen S.J., and Pankratz S.V. Twin studies of immunogenicity-determining the genetic contribution to vaccine failure. Vaccine 19 (2001) 2434-2439
5. Jacobson R.M., Ovsyannikova I.G., Targonski P.V., and Poland G.A. Studies of twins in vaccinology. Vaccine 25 16 (2007) 3160-3164
6. Ovsyannikova I.G., Jacobson R.M., Ryan J.E., Dhiman N., Vierkant R.A., and Poland G.A. Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination. Clin Vaccine Immunol 14 2 (2007) 115-122
7. Plotkin S.A., Reef S., Plotkin S.A., and Orenstein W.A. Vaccines. Rubella vaccine. fourth ed. (2004), Saunders, Philadelphia, PA 707-744
8. Ovsyannikova I.G., Jacobson R.M., Ryan J.E., Vierkant R.A., Pankratz V.S., Jacobsen S.J., et al. HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine. Immunogenetics 56 (2005) 798-807
9. Ovsyannikova I.G., Ryan J.E., Vierkant R.A., Pankratz S.V., Jacobson R.M., and Poland G.A. Immunologic significance of HLA class I genes in measles virus-specific IFN-gamma and IL-4 cytokine immune responses. Immunogenetics 57 11 (2005) 828-836
10. Ryan J.E., Ovsyannikova I.G., and Poland G.A. Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT. In: Kalyuzhyny A.E. (Ed). Handbook of ELISPOT: Methods and Protocols (2005), Humana Press Inc., Totowa, NJ 207-218
11. Ryan J.E., Ovsyannikova I.G., Dhiman N., Pinsky N.A., Vierkant R.A., Jacobson R.M., et al. Inter-operator variation in ELISPOT analysis of measles virus-specific IFN-gamma secreting T cells. Scand J Clin Lab Invest 65 8 (2005) 681-690
12. Ryan J.E., Dhiman N., Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., and Poland G.A. Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination. J Immunol Methods 341 (2009) 97-105
13. Dhiman N., Ovsyannikova I.G., Howe R.C., Ryan J.E., Jacobson R.M., and Poland G.A. Interleukin-4 induced by measles virus and measles-derived peptides as measured by IL-4 receptor-blocking ELISA. J Immunol Methods 287 1-2 (2004) 217-225
14. Guo S.W., and Thompson E.A. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48 (1992) 361-372
15. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13 (1995) 251-276
16. Dhiman N., Ovsyannikova I., Vierkant R., Pankratz V., Jacobson R., and Poland G. Associations between cytokine/cytokine receptor SNPs and humoral immunity to measles, mumps and rubella in a Somali population. Tissue Antigens 72 3 (2008) 211-220
17. Plotkin S.A. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J 20 (2001) 63-75
18. Pukhalsky A.L., Shmarina G.V., Bliacher M.S., Fedorova I.M., Toptygina A.P., Fisenko J.J., et al. Cytokine profile after rubella vaccine inoculation: evidence of the immunosuppressive effect of vaccination. Mediators Inflamm 12 4 (2003) 203-207
19. Dhiman N., Ovsyannikova I.G., Jacobson R.M., Vierkant R.A., Pankratz V.S., Jacobsen S.J., et al. Correlates of lymphoproliferative responses to measles, mumps, and rubella (MMR) virus vaccines following MMR-II vaccination in healthy children. Clin Immunol 115 2 (2005) 154-161
20. + T cells requires the coordinate action of interleukin-12 and interferon-γ and is inhibited be transforming growth factor-β. Eur J Immunol 24 (1994) 793-798
21. Puddu P., Fantuzzi L., Borghi P., Varano B., Rainaldi G., Guillemard E., et al. IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. J Immunol 159 7 (1997) 3490-3497
22. Orange J.S., Wang B., Terhorst C., and Biron C.A. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 182 4 (1995) 1045-1056
23. Sidney J., Grey H.M., Southwood S., Celis E., Wentworth P.A., del Guercio M.F., et al. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide-binding repertoires of common HLA molecules. Hum Immunol 45 2 (1996) 79-93
24. Randall R.E., and Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89 Pt 1 (2008) 1-47
25. Akaboshi I., Nagayoshi I., Omura M., and Iwaki K. Elevated serum levels of interleukin-10 in children with acute rubella infection. Scand J Infect Dis 33 6 (2001) 462-465
26. Shmarina G.V., Pukhalsky A.L., Kokarovtseva S.N., Pukhalskaya D.A., Shabalova L.A., Kapranov N.I., et al. Tumor necrosis factor-alpha/interleukin-10 balance in normal and cystic fibrosis children. Mediators Inflamm 10 4 (2001) 191-197
27. Bradley J.R. TNF-mediated inflammatory disease. J Pathol 214 2 (2008) 149-160
28. Kwiatkowski D., Hill A.V., Sambou I., Twumasi P., Castracane J., Manogue K.R., et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 336 8725 (1990) 1201-1204
29. Ivanov I.I., McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 6 (2006) 1121-1133
30. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 11 (2005) 1133-1141